Kura Oncology KURA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's short-term investments?
- Kura Oncology (KURA) reported short-term investments of $541.74M in Q1 2026.
- How has Kura Oncology's short-term investments changed year-over-year?
- Kura Oncology's short-term investments decreased by 10.7% year-over-year, from $606.92M to $541.74M.
- What is the long-term trend for Kura Oncology's short-term investments?
- Over 5 years (2020 to 2025), Kura Oncology's short-term investments has grown at a 11.0% compound annual growth rate (CAGR), from $307.83M to $518.14M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.